134 related articles for article (PubMed ID: 3986811)
1. Prognostic importance of serum ferritin in patients with Stages III and IV neuroblastoma: the Childrens Cancer Study Group experience.
Hann HW; Evans AE; Siegel SE; Wong KY; Sather H; Dalton A; Hammond D; Seeger RC
Cancer Res; 1985 Jun; 45(6):2843-8. PubMed ID: 3986811
[TBL] [Abstract][Full Text] [Related]
2. Biologic differences between neuroblastoma stages IV-S and IV. Measurement of serum ferritin and E-rosette inhibition in 30 children.
Hann HW; Evans AE; Cohen IJ; Leitmeyer JE
N Engl J Med; 1981 Aug; 305(8):425-9. PubMed ID: 7254280
[TBL] [Abstract][Full Text] [Related]
3. Neuroblastoma.
Meir HM; Balawi I; Nayel H; Yousef MK; Badawood S; Al-Mobarak M
Saudi Med J; 2001 Aug; 22(8):674-80. PubMed ID: 11573111
[TBL] [Abstract][Full Text] [Related]
4. Models to predict outcome from childhood neuroblastoma: the role of serum ferritin and tumor histology.
Silber JH; Evans AE; Fridman M
Cancer Res; 1991 Mar; 51(5):1426-33. PubMed ID: 1997181
[TBL] [Abstract][Full Text] [Related]
5. [Neuroblastoma at the Giannina Gaslini Institute. Analysis of 94 cases diagnosed 1972-1981].
De Bernardi B; Garaventa A; Bartolini M; Rizzo A; Rosanda C; Bisogni C; Melodia A; Magnaguagno G; Ricci G; Lamedica G
Pediatr Med Chir; 1983; 5(1-2):49-58. PubMed ID: 6634442
[TBL] [Abstract][Full Text] [Related]
6. Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies-a report from the Children's Cancer Group Study.
Rudnick E; Khakoo Y; Antunes NL; Seeger RC; Brodeur GM; Shimada H; Gerbing RB; Stram DO; Matthay KK
Med Pediatr Oncol; 2001 Jun; 36(6):612-22. PubMed ID: 11344492
[TBL] [Abstract][Full Text] [Related]
7. MYCN protein expression as a predictor of neuroblastoma prognosis.
Chan HS; Gallie BL; DeBoer G; Haddad G; Ikegaki N; Dimitroulakos J; Yeger H; Ling V
Clin Cancer Res; 1997 Oct; 3(10):1699-706. PubMed ID: 9815553
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of DNA di-tetraploidy in neuroblastoma.
Ladenstein R; Ambros IM; Pötschger U; Amann G; Urban C; Fink FM; Schmitt K; Jones R; Slociak M; Schilling F; Ritter J; Berthold F; Gadner H; Ambros PF
Med Pediatr Oncol; 2001 Jan; 36(1):83-92. PubMed ID: 11464912
[TBL] [Abstract][Full Text] [Related]
9. [Neuroblastoma: biological markers, surgery, and clinical course].
Martínez Ibáñez V; Abad P; Gallego S; Sánchez de Toledo J; Marqués A; Boix Ochoa J
Cir Pediatr; 2000 Apr; 13(2):47-53. PubMed ID: 12602001
[TBL] [Abstract][Full Text] [Related]
10. The serum ferritin concentration is a significant prognostic indicator of survival in primary lung cancer.
Milman N; Pedersen LM
Oncol Rep; 2002; 9(1):193-8. PubMed ID: 11748482
[TBL] [Abstract][Full Text] [Related]
11. Serum ferritin as a guide to therapy in neuroblastoma.
Hann HW; Levy HM; Evans AE
Cancer Res; 1980 May; 40(5):1411-3. PubMed ID: 6245792
[TBL] [Abstract][Full Text] [Related]
12. Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study.
Schmidt ML; Lal A; Seeger RC; Maris JM; Shimada H; O'Leary M; Gerbing RB; Matthay KK
J Clin Oncol; 2005 Sep; 23(27):6474-80. PubMed ID: 16116154
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of the detection of microcirculating tumor cells by a real-time RT-PCR assay of tyrosine hydroxylase in patients with advanced neuroblastoma.
Parareda A; Gallego S; Roma J; Llort A; Sábado C; Gros L; De Toledo JS
Oncol Rep; 2005 Oct; 14(4):1021-7. PubMed ID: 16142367
[TBL] [Abstract][Full Text] [Related]
14. Presenting features and treatment outcome of 78 Malaysian children with neuroblastoma.
Ng SM; Abdullah WA; Lin HP; Chan LL
Southeast Asian J Trop Med Public Health; 1999 Mar; 30(1):149-53. PubMed ID: 10695803
[TBL] [Abstract][Full Text] [Related]
15. Prospective validation of serum CYFRA 21-1, beta-2-microglobulin, and ferritin levels as prognostic markers in patients with nonmetastatic nasopharyngeal carcinoma undergoing radiotherapy.
Ma BB; Leungm SF; Hui EP; Mo F; Kwan WH; Zee B; Yuen J; Chan AT
Cancer; 2004 Aug; 101(4):776-81. PubMed ID: 15305409
[TBL] [Abstract][Full Text] [Related]
16. [Clinical features and prognosis of advanced neuroblastoma in children].
Gao XN; Tang SQ; Lin J
Zhongguo Dang Dai Er Ke Za Zhi; 2007 Aug; 9(4):351-4. PubMed ID: 17706038
[TBL] [Abstract][Full Text] [Related]
17. Neuroblastoma in adolescents.
Gaspar N; Hartmann O; Munzer C; Bergeron C; Millot F; Cousin-Lafay L; Babin-Boilletot A; Blouin P; Pajot C; Coze C
Cancer; 2003 Jul; 98(2):349-55. PubMed ID: 12872356
[TBL] [Abstract][Full Text] [Related]
18. Neuroblastoma in adolescents: the Italian experience.
Conte M; Parodi S; De Bernardi B; Milanaccio C; Mazzocco K; Angelini P; Viscardi E; Di Cataldo A; Luksch R; Haupt R
Cancer; 2006 Mar; 106(6):1409-17. PubMed ID: 16475209
[TBL] [Abstract][Full Text] [Related]
19. [Treatment results of neuroblastoma in children in the Republic of Belarus].
Proleskovskaia IV; Savich TV; Mareĭko IuE; Savva NN; Aleĭnikova OV
Vopr Onkol; 2009; 55(2):215-20. PubMed ID: 19514379
[TBL] [Abstract][Full Text] [Related]
20. [The prognostic effect of amplification of the MYCN oncogene in neuroblastoma. The preliminary results of the Italian Cooperative Group for Neuroblastoma (GCINB)].
Pession A; De Bernardi B; Perri P; Mazzocco K; Rondelli R; Nigro M; Iolascon A; Forni M; Basso G; Conte M
Pediatr Med Chir; 1994; 16(3):211-8. PubMed ID: 7971442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
